(BCY) Barclays - Ratings and Ratios
Banking, Cards, Lending, Investments, Wealth
BCY EPS (Earnings per Share)
BCY Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 29.0% |
| Value at Risk 5%th | 46.0% |
| Reward | |
|---|---|
| Sharpe Ratio | 1.37 |
| Alpha | 38.00 |
| Character | |
|---|---|
| Hurst Exponent | 0.351 |
| Beta | 0.911 |
| Drawdowns 3y | |
|---|---|
| Max DD | 27.33% |
| Mean DD | 7.18% |
Description: BCY Barclays September 26, 2025
Barclays PLC (XETRA: BCY) is a globally diversified financial services firm headquartered in London, operating across retail, corporate, private-banking, investment-banking and US consumer-bank segments in the UK, Europe, the Americas, Africa, the Middle East and Asia.
Its product suite includes retail deposits, credit-card issuance, wholesale and investment banking, wealth-management and asset-management services, as well as a range of lending products. The firm also conducts securities-dealing activities and generates fee income from capital-markets transactions.
Key quantitative snapshots (as of FY 2024): a Common Equity Tier 1 (CET1) ratio of 14.5 %-well above the Basel III minimum-net interest income of £12.4 bn, and a loan-book growth of 3.2 % YoY, driven primarily by UK corporate and US consumer loan expansions. The bank’s cost-to-income ratio has compressed to 58 % after a multi-year efficiency programme, reflecting ongoing digitisation and branch-right-sizing.
Sector-level drivers that materially affect Barclays include the Bank of England’s policy-rate trajectory (currently 5.25 % and expected to stay high through 2025), which underpins net interest margins, and tightening regulatory capital requirements that pressure return on equity. Additionally, the acceleration of digital banking adoption in Europe and North America creates both cost-saving opportunities and competitive pressure from fintech entrants.
If you want a data-rich, model-based assessment of how these fundamentals translate into valuation, the ValueRay platform offers a transparent, quantitative framework worth exploring.
BCY Stock Overview
| Market Cap in USD | 76,802m |
| Sub-Industry | Diversified Banks |
| IPO / Inception | |
| Return 12m vs S&P 500 | 33.3% |
| Analyst Rating | - |
BCY Dividends
| Dividend Yield | 2.32% |
| Yield on Cost 5y | 8.82% |
| Yield CAGR 5y | 11.58% |
| Payout Consistency | 88.8% |
| Payout Ratio | 13.8% |
BCY Growth Ratios
| CAGR | 41.67% |
| CAGR/Max DD Calmar Ratio | 1.52 |
| CAGR/Mean DD Pain Ratio | 5.81 |
| Current Volume | 101.5k |
| Average Volume | 146.9k |
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (6.91b TTM) > 0 and > 6% of Revenue (6% = 2.34b TTM) |
| FCFTA 0.00 (>2.0%) and ΔFCFTA 0.54pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -1084 % (prev 872.4%; Δ -1957 pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.00 (>3.0%) and CFO 7.11b > Net Income 6.91b (YES >=105%, WARN >=100%) |
| Net Debt (-49.09b) to EBITDA (13.14b) ratio: -3.74 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.33 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (13.97b) change vs 12m ago -4.61% (target <= -2.0% for YES) |
| Gross Margin 36.38% (prev 98.41%; Δ -62.03pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 2.56% (prev 1.58%; Δ 0.98pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -0.03 (EBITDA TTM 13.14b / Interest Expense TTM 25.39b) >= 6 (WARN >= 3) |
Altman Z'' -1.66
| (A) -0.28 = (Total Current Assets 210.18b - Total Current Liabilities 633.84b) / Total Assets 1518.20b |
| (B) 0.04 = Retained Earnings (Balance) 56.03b / Total Assets 1518.20b |
| (C) -0.00 = EBIT TTM -787.0m / Avg Total Assets 1524.67b |
| (D) 0.05 = Book Value of Equity 71.24b / Total Liabilities 1445.72b |
| Total Rating: -1.66 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 55.37
| 1. Piotroski 4.0pt = -1.0 |
| 2. FCF Yield 40.60% = 5.0 |
| 3. FCF Margin 14.18% = 3.54 |
| 4. Debt/Equity 2.30 = 0.31 |
| 5. Debt/Ebitda -3.74 = 2.50 |
| 6. ROIC - WACC (= -11.71)% = -12.50 |
| 7. RoE 9.42% = 0.78 |
| 8. Rev. Trend 55.28% = 4.15 |
| 9. EPS Trend 51.66% = 2.58 |
What is the price of BCY shares?
Over the past week, the price has changed by +2.37%, over one month by +11.23%, over three months by +10.32% and over the past year by +53.59%.
Is Barclays a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BCY is around 4.78 EUR . This means that BCY is currently overvalued and has a potential downside of 0.42%.
Is BCY a buy, sell or hold?
What are the forecasts/targets for the BCY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 5.6 | 18.1% |
BCY Fundamental Data Overview January 01, 1970
Market Cap GBP = 58.45b (66.54b EUR * 0.8785 EUR.GBP)
P/E Trailing = 10.337
P/E Forward = 7.5245
P/S = 2.5575
P/B = 0.7114
P/EG = 1.32
Beta = 0.911
Revenue TTM = 39.07b GBP
EBIT TTM = -787.0m GBP
EBITDA TTM = 13.14b GBP
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 165.38b GBP (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -49.09b GBP (from netDebt column, last fiscal year)
Enterprise Value = 13.64b GBP (58.45b + Debt 165.38b - CCE 210.18b)
Interest Coverage Ratio = -0.03 (Ebit TTM -787.0m / Interest Expense TTM 25.39b)
FCF Yield = 40.60% (FCF TTM 5.54b / Enterprise Value 13.64b)
FCF Margin = 14.18% (FCF TTM 5.54b / Revenue TTM 39.07b)
Net Margin = 17.69% (Net Income TTM 6.91b / Revenue TTM 39.07b)
Gross Margin = 36.38% ((Revenue TTM 39.07b - Cost of Revenue TTM 24.86b) / Revenue TTM)
Gross Margin QoQ = 100.0% (prev 13.48%)
Tobins Q-Ratio = 0.01 (Enterprise Value 13.64b / Total Assets 1518.20b)
Interest Expense / Debt = 15.35% (Interest Expense 25.39b / Debt 165.38b)
Taxrate = 21.61% (1.75b / 8.11b)
NOPAT = -616.9m (EBIT -787.0m * (1 - 21.61%)) [loss with tax shield]
Current Ratio = 0.33 (Total Current Assets 210.18b / Total Current Liabilities 633.84b)
Debt / Equity = 2.30 (Debt 165.38b / totalStockholderEquity, last fiscal year 71.82b)
Debt / EBITDA = -3.74 (Net Debt -49.09b / EBITDA 13.14b)
Debt / FCF = -8.86 (Net Debt -49.09b / FCF TTM 5.54b)
Total Stockholder Equity = 73.39b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.46% (Net Income 6.91b / Total Assets 1518.20b)
RoE = 9.42% (Net Income TTM 6.91b / Total Stockholder Equity 73.39b)
RoCE = -0.09% (EBIT -787.0m / Capital Employed (Total Assets 1518.20b - Current Liab 633.84b))
RoIC = -0.29% (negative operating profit) (NOPAT -616.9m / Invested Capital 211.70b)
WACC = 11.42% (E(58.45b)/V(223.83b) * Re(9.66%) + D(165.38b)/V(223.83b) * Rd(15.35%) * (1-Tc(0.22)))
Discount Rate = 9.66% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.59%
[DCF Debug] Terminal Value 63.51% ; FCFE base≈5.54b ; Y1≈3.64b ; Y5≈1.66b
Fair Price DCF = 1.83 (DCF Value 25.54b / Shares Outstanding 13.92b; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 51.66 | EPS CAGR: 117.7% | SUE: N/A | # QB: 0
Revenue Correlation: 55.28 | Revenue CAGR: 11.58% | SUE: N/A | # QB: 0